{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:26:40Z","timestamp":1776738400844,"version":"3.51.2"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1016\/s1471-4914(01)01986-4","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T21:15:02Z","timestamp":1027631702000},"page":"201-204","source":"Crossref","is-referenced-by-count":500,"title":["Clinical application of pharmacogenetics"],"prefix":"10.1016","volume":"7","author":[{"given":"Brian B","family":"Spear","sequence":"first","affiliation":[]},{"given":"Margo","family":"Heath-Chiozzi","sequence":"additional","affiliation":[]},{"given":"Jeffrey","family":"Huff","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1471-4914(01)01986-4_BIB1","unstructured":"Physicians\u2019 Desk Reference, 54th Edn., 2000"},{"key":"10.1016\/S1471-4914(01)01986-4_BIB2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients","volume":"279","author":"Lazarou","year":"1998","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/S1471-4914(01)01986-4_BIB3","doi-asserted-by":"crossref","unstructured":"Vesell, E.S. Pharmacogenetics perspectives gained from twin and family studies. In Pharmacogenetics of Drug Metabolism (Kalow,W., ed.), pp. 843\u2013863 Pergamon","DOI":"10.1016\/0163-7258(89)90130-7"},{"key":"10.1016\/S1471-4914(01)01986-4_BIB4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.286.5439.487","article-title":"Pharmacogenomics: translating functional genomics into rational therapeutics","volume":"286","author":"Evans","year":"1999","journal-title":"Science"},{"key":"10.1016\/S1471-4914(01)01986-4_BIB5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.277.4.301","article-title":"Adverse drug events in hospitalized patients","volume":"227","author":"Classen","year":"1997","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/S1471-4914(01)01986-4_BIB6","unstructured":"Remick, D.G. et al. (1990) Theory and applications of the polymerase chain reaction. Am. J. Clin. Pathol. S49\u2013S54"},{"key":"10.1016\/S1471-4914(01)01986-4_BIB7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1515\/CCLM.1998.045","article-title":"Developments in quantitative PCR","volume":"36","author":"Orlando","year":"1988","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/S1471-4914(01)01986-4_BIB8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1084-8592(99)80012-5","article-title":"Clinical, genetic, and pharmacogenetic applications of the invader assay","volume":"4","author":"Kwiatkowski","year":"1999","journal-title":"Mol. Diag."},{"key":"10.1016\/S1471-4914(01)01986-4_BIB9","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1128\/JCM.38.9.3205-3208.2000","article-title":"Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy\u2019","volume":"38","author":"Chan","year":"2000","journal-title":"J.Clin. Microbiol."},{"key":"10.1016\/S1471-4914(01)01986-4_BIB10","unstructured":"Wetzsteon, P.J. (1997) Understanding sequence-based typing. ASHI Quarterly, Fall, pp.167\u2013180"},{"key":"10.1016\/S1471-4914(01)01986-4_BIB11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/4253","article-title":"DNA chips \u2013 an array of possibilities","volume":"16","author":"Marshall","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/S1471-4914(01)01986-4_BIB12","doi-asserted-by":"crossref","unstructured":"Nat. Genet. (1999) Vol. 21, Supplement, pp. 1\u201360","DOI":"10.1038\/4423"},{"key":"10.1016\/S1471-4914(01)01986-4_BIB13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1101\/gr.7.6.606","article-title":"Minisequencing: aspecific tool for DNA analysis and diagnostics on oligonucleotide arrays","volume":"7","author":"Pastinene","year":"1997","journal-title":"Genome Res."},{"key":"10.1016\/S1471-4914(01)01986-4_BIB14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00008571-199512000-00008","article-title":"Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy","volume":"5","author":"Furuya","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S1471-4914(01)01986-4_BIB15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00008571-199512000-00001","article-title":"The pharmacogenetics of codeine hypoalgesia","volume":"5","author":"Sindrup","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S1471-4914(01)01986-4_BIB16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/clpt.1989.119","article-title":"Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism","volume":"46","author":"Lennard","year":"1989","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/S1471-4914(01)01986-4_BIB17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008571-199608000-00001","article-title":"Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms","volume":"6","author":"Krynetski","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/S1471-4914(01)01986-4_BIB18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/ajrccm.162.1.9907092","article-title":"The effect of polymorphisms of the \u03b22-adrenergic receptor on the response to regular use of albuterol in asthma","volume":"162","author":"Israel","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/S1471-4914(01)01986-4_BIB19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/9680","article-title":"Pharmacogenetic association between ALOX5 promotor genotype and the response to anti-asthma treatment","volume":"22","author":"Drazen","year":"1999","journal-title":"Nat. Genet."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491401019864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491401019864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:12:04Z","timestamp":1580227924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491401019864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S1471491401019864"],"URL":"https:\/\/doi.org\/10.1016\/s1471-4914(01)01986-4","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}